Oat Relief Serum Base

1. INCI & CAS

INCI: Avena Sativa Kernel Extract · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Avena sativa kernel extract is a cosmetic oat fraction. Beta-glucan content is supplier-specific. Do not claim a drug eczema treatment.

3. Typical use levels (formulation guide)

• Lotions and creams: 0.5–2% as a formulation guide.

Add in cool-down.

4. Regulatory sources & global compliance

• If CosIng lists Avena Sativa Kernel Extract, that listing remains ingredient information; check rules for the intended market and use.
• Before EU placement, Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Avena Sativa Kernel Extract rather than for an ingredient name alone.
• Establish grade-specific details for Avena Sativa Kernel Extract from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; the listed level does not itself confer drug or OTC status and the completed formula still requires stability and patch testing.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Avena Sativa Kernel Extract highlights oat comfort.

• The ingredient record does not support medical outcomes, cure language, or a product certification not supported by the available facts.
• This guide to Avena Sativa Kernel Extract offers no support for whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Bisabolol · CAS: 23089-26-1

2. Role in the formula

Bisabolol is a monocyclic sesquiterpene alcohol used at low levels in leave-on cosmetics. Prefer the grade named on the supplier TDS.

3. Typical use levels (formulation guide)

• The stated reference for leave-on is 0.1–0.5% in this reference.

The guide places Bisabolol in the oil phase.

4. Regulatory sources & global compliance

• CosIng may identify Bisabolol as an ingredient, but its entry does not approve a material grade or finished formula.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety assessment covering the complete formulation with Bisabolol rather than for an ingredient name alone.
• Use the supplier TDS to confirm grade-specific details for Bisabolol and review the destination market's requirements.

5. Safety & risk assessment

The percentage is shown for cosmetic development; the note establishes neither drug approval nor OTC-monograph status so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; choose a package with oxidation sensitivity in view; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The cosmetic concept for Bisabolol in this entry centers on bisabolol comfort.

• This product entry cannot substantiate drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• This reference for Bisabolol does not demonstrate skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The reference uses glycerin as a polyol humectant across washes, gels, and emulsions. Treat the percentage as development guidance.

3. Typical use levels (formulation guide)

• The formulation record indicates 3–8% for gels and serums as a formulation guide.
• 2–5% is listed for creams for the formula.
• The stated reference for rinse-off is 2–4%.

Use the water phase to introduce Glycerin; no melting stage is required.

4. Regulatory sources & global compliance

• If CosIng lists Glycerin, that listing remains ingredient information; check rules for the intended market and use.
• Before EU placement, Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Glycerin before release of the finished cosmetic.
• Use current supplier documentation for the purchased Glycerin grade and verify applicable destination-market filings.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; the listed level does not itself confer drug or OTC status and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; choose a package with oxidation sensitivity in view; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Glycerin centers on humectant function.

• The listed information does not establish therapeutic results, cure claims, or unverified certification claims.
• The cosmetic guidance for Glycerin does not substantiate whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.